From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting <scp>LOXL2</scp> in Breast Cancer
- DOI
- 10.1111/cbdd.70320
- Published
- 2026-05-28
- Container
- Chemical Biology & Drug Design
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/cbdd.70320,
title = {From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting
<scp>LOXL2</scp>
in Breast Cancer},
author = {Sandra Ferreira and Beatriz Santos and Matilde Tavares and Serhii Holota and Dmytro Khylyuk and Roman Lesyk and Natalia Finyuk and Daniel J. V. A. dos Santos and Ana M. Díaz‐Lanza and João G. Costa and Nuno Saraiva and Ana S. Fernandes},
year = {2026},
journal = {Chemical Biology \& Drug Design},
doi = {10.1111/cbdd.70320},
url = {https://doi.org/10.1111/cbdd.70320}
}RIS
TY - JOUR
TI - From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting
<scp>LOXL2</scp>
in Breast Cancer
AU - Sandra Ferreira
AU - Beatriz Santos
AU - Matilde Tavares
AU - Serhii Holota
AU - Dmytro Khylyuk
AU - Roman Lesyk
AU - Natalia Finyuk
AU - Daniel J. V. A. dos Santos
AU - Ana M. Díaz‐Lanza
AU - João G. Costa
AU - Nuno Saraiva
AU - Ana S. Fernandes
PY - 2026
JO - Chemical Biology & Drug Design
DO - 10.1111/cbdd.70320
UR - https://doi.org/10.1111/cbdd.70320
ER - APA
Ferreira, S., Santos, B., Tavares, M., Holota, S., Khylyuk, D., Lesyk, R., Finyuk, N., Santos, D. J. V. A. D., Díaz‐Lanza, A. M., Costa, J. G., Saraiva, N., & Fernandes, A. S. (2026). From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting <scp>LOXL2</scp> in Breast Cancer. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70320
Source records
- crossref · retrieved 2026-09-25T18:25:35.189Z